Frederick W. Gluck, Director at CytomX Therapeutics, Inc. (CTMX), bought 15,000 shares at $12.00 ($180K) on 2015-10-14, disclosed to the SEC on 2015-10-16.
Open-market purchase of $180k CTMX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.00 | 5,000 | $60K | 33.3% |
| 2 | $12.00 | 10,000 | $120K | 66.7% |
| Total | $12.00 avg | 15,000 | $180K | 100% |
| Filing → |
| CTMX | SELL | 2018-03-02 | $115K | — | Filing → |
| CTMX | SELL | 2018-01-08 | $500K | — | Filing → |
| CTMX | SELL | 2017-12-28 | $111K | — | Filing → |